Daily Anesthesiology Research Analysis
Today's top anesthesiology-relevant studies span translational organ perfusion immunoengineering, global pain epidemiology, and perioperative systems safety. Enzymatic conversion of blood group antigens during machine perfusion prevented hyperacute injury in an ABO-incompatible kidney, a meta-analysis quantified complex regional pain syndrome risk after injuries/surgeries, and a nationwide cohort linked after-hours surgery with higher mortality and complications.
Summary
Today's top anesthesiology-relevant studies span translational organ perfusion immunoengineering, global pain epidemiology, and perioperative systems safety. Enzymatic conversion of blood group antigens during machine perfusion prevented hyperacute injury in an ABO-incompatible kidney, a meta-analysis quantified complex regional pain syndrome risk after injuries/surgeries, and a nationwide cohort linked after-hours surgery with higher mortality and complications.
Research Themes
- Organ perfusion immunoengineering to overcome ABO incompatibility
- Risk stratification for complex regional pain syndrome in high-risk surgical/trauma cohorts
- Perioperative systems timing (after-hours surgery) and patient safety
Selected Articles
1. Enzymatic conversion of blood group B kidney prevents hyperacute antibody-mediated injuries in ABO-incompatible transplantation.
Using α-galactosidase during hypothermic machine perfusion, >95% of B antigens were removed from donor kidneys, preventing antibody-mediated injury in ex vivo ABO-incompatible simulations. A converted B kidney transplanted into an O-type brain-dead recipient survived 63 hours without hyperacute rejection, despite re-expression of B antigens by 48 hours.
Impact: This offers a potentially paradigm-shifting, perfusion-based strategy to enable ABO-incompatible kidney transplantation without conventional desensitization. It could expand the donor pool and reduce waiting times.
Clinical Implications: If validated, enzyme treatment during machine perfusion could be integrated into transplant workflows to convert incompatible kidneys, potentially reducing rejection risk and obviating intense desensitization. Anesthesiologists and perioperative teams should anticipate perfusion-based organ conditioning protocols.
Key Findings
- α-galactosidase treatment during hypothermic perfusion removed >95% of B antigens from kidney endothelium within 3 hours.
- Ex vivo ABO-incompatible simulation showed enzyme-treated kidneys were protected from antibody-mediated injuries.
- A converted type B kidney transplanted into a type O brain-dead recipient survived 63 hours without hyperacute rejection; B antigens re-expressed within 48 hours without histologic AMR.
Methodological Strengths
- Translational validation across ex vivo perfusion, simulated incompatible challenge, and a human feasibility transplant.
- Quantitative antigen removal with histopathology to assess antibody-mediated injury.
Limitations
- Single human feasibility case with short (63-hour) observation; no long-term outcomes.
- Re-expression of blood group antigens within 48 hours raises durability and immunogenicity questions.
Future Directions: Conduct multi-center clinical trials to assess safety, durability of antigen removal, dosing/kinetics, and applicability to A antigens and other organs under machine perfusion.
Matching ABO blood group antigens between donors and recipients is critical to prevent hyperacute rejection in kidney transplantation. Enzymatic conversion of blood group antigens to the universal O type presents a promising strategy to overcome barriers in ABO-incompatible kidney transplantation. In this study, we employ α-galactosidase from Bacteroides fragilis to convert type B kidneys to type O during hypothermic machine perfusion. After 3 hours of perfusion with enzyme, more than 95% of blood group B antigens in the kidney endothelium are effectively removed. Subsequently, enzyme-treated kidneys are protected from antibody-mediated injuries in an ex vivo simulation of ABO-incompatible kidney transplantation. Encouraged by these results, a discarded type B kidney, following enzymatic conversion, is transplanted into a type O brain-dead recipient with high titer of anti-B antibody. The allograft survives for 63 hours without hyperacute rejection. Blood group B antigens re-express within 48 hours, with histopathological analyses indicating no evidence of antibody-mediated rejection. This enzymatic conversion approach holds the potential to broaden the practice of ABO-incompatible kidney transplantation, decrease waiting times and facilitate equitable organ allocation.
2. Global Burden of Complex Regional Pain Syndrome in At-Risk Populations: Estimates of Prevalence From 35 Countries Between 1993 and 2023.
Across 214 studies from 35 countries (n≈2.49 million), pooled CRPS prevalence after inciting events was 3.04% at 12 months and 6.46% at 24 months. Prevalence was higher after traumatic versus surgical inciting injuries, in higher-HDI settings, and in prospective versus retrospective designs; more recent studies reported lower 12-month prevalence.
Impact: Provides the largest benchmark of CRPS risk after fractures/surgeries, directly informing screening, prevention, and resource allocation in perioperative and trauma care.
Clinical Implications: Clinicians should counsel high-risk patients (especially post-trauma) that CRPS risk approaches 3–6% within 1–2 years, and implement early detection/prevention protocols. Programs can target modifiable factors and allocate follow-up resources where risk is highest.
Key Findings
- Pooled global CRPS prevalence among at-risk individuals was 3.04% at 12 months and 6.46% at 24 months.
- Higher prevalence was observed after traumatic inciting injuries versus surgical injuries, and in higher-HDI countries.
- Prospective studies reported higher prevalence than retrospective studies; publication year moderated prevalence (recent studies reported lower 12-month prevalence).
Methodological Strengths
- Large-scale systematic review and meta-analysis (214 studies; ~2.49 million participants) with random-effects pooling.
- Subgroup analyses and meta-regression to explore population, contextual, and methodological moderators.
Limitations
- Heterogeneity across studies and diagnostic ascertainment differences likely influence pooled estimates.
- Prevalence differences by design (prospective vs retrospective) suggest potential measurement and selection biases.
Future Directions: Standardize diagnostic criteria and prospective surveillance in high-risk surgical and trauma cohorts to refine risk prediction and test targeted prevention strategies.
BACKGROUND: Complex regional pain syndrome (CRPS) is a debilitating and painful condition accompanied by sensory, autonomic, trophic, and/or motor abnormalities. Although CRPS is rare in the general population, the prevalence among individuals at higher risk, particularly posttraumatic and postsurgical patients, remains unknown. This study aims to provide a benchmark that quantifies CRPS prevalence in high-risk groups, and offers insights on potential predictors of developing CRPS. METHODS: We conducted a systematic review and meta-analysis to identify studies reporting prevalence of CRPS after an inciting event (eg, fracture, surgery), specifically 12-month and 24-month prevalence (primary outcomes), as well as 3-month and 6-month prevalence (secondary outcomes). Estimates from individual studies were transformed using double-arcsine transformation, and the resulting estimates with 95% confidence interval (CI) were pooled in a meta-analysis using a random-effects model. RESULTS: We included 214 articles with data from 2491,378 participants worldwide (35 countries), of which 16,873 had CRPS. The pooled 12-month and 24-month global prevalence was 3.04% (95% CI, 2.64-3.48) and 6.46% (95% CI, 5.46-7.53), respectively. Subgroup analysis and meta-regression were performed to understand the impact of population-dependent (mechanism of injury, type of CRPS), contextual-dependent (socioeconomic status), and methodological-dependent (study design, publication year) factors. The 12-month prevalence was higher in countries with a high human development index (HDI) compared to those with a medium or very high HDI, was higher in participants with a traumatic inciting injury only versus those with surgical injury only or traumatic/surgical injury, and was higher in prospective versus retrospective studies. Meta-regression analysis showed that publication year was a significant moderator, with more recent articles reporting lower 12-month prevalence. CONCLUSIONS: This study provides a benchmark of the global prevalence of CRPS, which anesthesiologists and pain specialists can use to prioritize early diagnosis and identify those at the highest risk for CRPS.
3. Outcomes of after-hours surgeries performed under general anaesthesia: a South Korean nationwide cohort study.
In a propensity-matched national cohort (n=281,717), after-hours surgeries under general anesthesia had significantly higher 90-day mortality (OR 3.58), 1-year mortality (HR 2.51), and postoperative complications (OR 2.14) compared with in-hours surgeries.
Impact: Quantifies the ‘after-hours effect’ on perioperative outcomes at national scale, informing staffing, scheduling, and risk communication.
Clinical Implications: Elective and semi-urgent cases should, where feasible, be scheduled in-hours; after-hours cases warrant heightened vigilance, enhanced staffing, and mitigation protocols. Use findings in shared decision-making and perioperative risk stratification.
Key Findings
- After-hours surgeries had higher 90-day mortality (OR 3.58, 95% CI 3.47–3.69) versus in-hours.
- After-hours surgeries had higher 1-year all-cause mortality (HR 2.51, 95% CI 2.46–2.57).
- Postoperative complications were more frequent after-hours (OR 2.14, 95% CI 2.10–2.19).
Methodological Strengths
- Very large nationwide administrative cohort with propensity score matching (1:5) to reduce confounding.
- Clear, patient-centered outcomes (90-day and 1-year mortality) and complication assessment.
Limitations
- Observational design with potential residual confounding and case-mix differences.
- Limited granularity on intraoperative factors (e.g., staffing levels, clinician experience, urgency nuances).
Future Directions: Prospective studies assessing targeted staffing and protocolized mitigation during after-hours, and causal inference approaches to disentangle urgency and resource factors.
INTRODUCTION: The day of the week or time of day that surgery is performed may influence postoperative mortality or complications. We aimed to examine whether surgery under general anaesthesia performed after-hours was associated with increased rates of mortality and morbidity, compared with surgery performed in-hours. METHODS: This population-based cohort study obtained data for patients who underwent surgery under general anaesthesia from the National Health Insurance Service of South Korea. Propensity score-matched groups of patients who underwent surgery either in-hours (weekdays between 9.00 and 18.00) or after-hours (weekdays between 18.00 and 09.00 or on a weekend/holiday) were compared for 90-day and 1-year mortality, and the incidence postoperative complications. RESULTS: A total of 1,416,844 patients were considered (63,567 in the after-hours group and 1,353,277 in the in-hours group) and after a 1:5 propensity score matching, 281,717 were included (57,497 in the after-hours group and 224,220 in the in-hours group). Patients in the after-hours group showed 3.58-fold (OR 3.58, 95%CI 3.47-3.69, p < 0.001) and 2.51-fold (hazard ratio 2.51, 95%CI 2.46-2.57, p < 0.001) higher 90-day and 1-year all-cause mortality rates, respectively, compared with those in the in-hours group. Patients in the after-hours group had a 2.14-fold (OR 2.14, 95%CI 2.10-2.19, p < 0.001) greater incidence of postoperative complications compared with those in the in-hours group. DISCUSSION: After-hours surgery was associated with a higher risk of death within 90 days, an increase in all-cause mortality after 1-year and a higher incidence of postoperative complications.